← The SEC Ephemeris: the whole map
Hospira, Inc. Daptomycin
In the graph: all 5 documents (10 pages).
- Application
- NDA 219112
- Ticker
- Hospira, Inc.
- Product
- Daptomycin
- Disease area
- Not yet classified
- Response path
- Not yet classified
- Complete Response Letters
- January 17, 2025 · March 19, 2018 · February 22, 2018 · November 3, 2017 · April 26, 2017
From FDA letters and SEC filings. Not investment or medical advice.